课题基金 / 基金详情

Circulating tumour DNA analysis to predict and monitor minimal residual disease in breast cancer patients undergoing neoadjuvant treatment

Circulating tumour DNA analysis to predict and monitor minimal residual disease in breast cancer patients undergoing neoadjuvant treatment
循环肿瘤 DNA 分析可预测和监测接受新辅助治疗的乳腺癌患者的微小残留病
批准号：
449840
负责人：
Main Sasha C
金额：
$1.27万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2021-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=449840&lang=en
关键词：
Breast Cancer Capp-Seq Cell-Free Dna Cfmedip-Seq Circulating Tumour Dna Liquid Biopsy Minimal Residual Disease Novel Biomarkers

项目摘要

项目成果

Main Sasha C的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Breast cancer is the second most diagnosed cancer in Canada, with 27,700 Canadians expected to be diagnosed in 2020. Despite recent progress in breast cancer survival rates, about 20 percent of patients relapse and die from metastatic disease. Many of the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The use of cell-free DNA fragmentation patterns to enable precision medicine in breast cancer
  • 批准号：
    491635
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $2.55万
  • 财政年份：
    2023
  • 负责人：
    Main Sasha C
  • 依托单位：
    University Health Network (Toronto)